Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin V M L Jie

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 12, 2021
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's DiseaseCaitlin V M L Jie, Valerie Treyer, Roger Schibli, et al.
Chemmedchem|April 18, 2024
Developing Low Molecular Weight PET and SPECT Imaging AgentsLian Xue, Caitlin V M L Jie, Sandrine Desrayaud, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 27, 2025
Discovery of 1,3,4-Oxadiazin-5-One Derivative CJ1-34 as a Partial ATP Synthase Inhibitor for CNS ApplicationsCaitlin V M L Jie, Aro Delparente, Lisa Reichert, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2024
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative DiseasesYingfang He, Aro Delparente, Caitlin V M L Jie, et al.
Nature Communications|April 15, 2026
ATP synthase is a promising target for identifying activated and non-activated adipose tissuesCaitlin V M L Jie, Aro Delparente, Tongtong Wang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 28, 2022
Rest/stress myocardial perfusion imaging by positron emission tomography with <sup>18</sup>F-Flurpiridaz: A feasibility study in miceSusan Bengs, Geoffrey I Warnock, Angela Portmann, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|February 12, 2021
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's DiseaseCaitlin V M L Jie, Valerie Treyer, Roger Schibli, et al.
Chemmedchem|April 18, 2024
Developing Low Molecular Weight PET and SPECT Imaging AgentsLian Xue, Caitlin V M L Jie, Sandrine Desrayaud, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 27, 2025
Discovery of 1,3,4-Oxadiazin-5-One Derivative CJ1-34 as a Partial ATP Synthase Inhibitor for CNS ApplicationsCaitlin V M L Jie, Aro Delparente, Lisa Reichert, et al.
Chembiochem : a European Journal of Chemical Biology|March 5, 2024
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative DiseasesYingfang He, Aro Delparente, Caitlin V M L Jie, et al.
Nature Communications|April 15, 2026
ATP synthase is a promising target for identifying activated and non-activated adipose tissuesCaitlin V M L Jie, Aro Delparente, Tongtong Wang, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|April 28, 2022
Rest/stress myocardial perfusion imaging by positron emission tomography with <sup>18</sup>F-Flurpiridaz: A feasibility study in miceSusan Bengs, Geoffrey I Warnock, Angela Portmann, et al.
Pageof 1